PK/PD and NCA can be time-consuming, requiring careful attention at every step – from data import to report generation. Phoenix WinNonlin streamlines these processes with reproducible workflows, enabling collaborative and compliant PK/PD at scale.
As the industry standard for NCA, PK/PD studies, and toxicokinetic (TK) modeling, Phoenix WinNonlin delivers 30 years of reliability and innovation. Trusted by regulatory agencies like the FDA, PMDA, CFDA, and MHRA, it ensures compliance, reduces manual effort, and enhances productivity. 
Versatility for the PK/PD Scientist Certara Phoenix WinNonlin 8.4
Phoenix WinNonlin™ simplifies complex pharmacokinetic and pharmacodynamic data analysis, offering intuitive dataset preparation and streamlined workflows. Its robust NCA engine supports a wide range of studies, from early non-clinical research to large clinical trials.
Why Certara, crack license Certara Phoenix WinNonlin 8.4
Certara empowers drug development with innovative software solutions and expert guidance, ensuring success at every stage.
- Phoenix software is widely recognized and accepted by both industry leaders and regulatory authorities
- Certara boasts a 30-year legacy in developing pharmacokinetic (PK) analysis and modeling software
- Our team brings extensive knowledge in pharmacokinetics and pharmacometrics, supported by leading experts in the field
